DFD-29 + Doxycycline + Placebo

Phase 3Completed

0 watching 0 views this week📈 Rising

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

✓

Phase 2

Phase 3

Approved

Indication / Disease

Papulopustular Rosacea

Conditions

Papulopustular Rosacea

Trial Timeline

Mar 14, 2022 → Jun 30, 2023

NCT ID

NCT05296629

About DFD-29 + Doxycycline + Placebo

DFD-29 + Doxycycline + Placebo is a phase 3 stage product being developed by Dr. Reddy's Laboratories for Papulopustular Rosacea. The current trial status is completed. This product is registered under clinical trial identifier NCT05296629. Target conditions include Papulopustular Rosacea.

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (2)

NCT ID	Phase	Status	Start	Completion	Indication
NCT05343455	Phase 3	Completed	Mar 29, 2022	Jun 30, 2023	Papulopustular Rosacea
NCT05296629	Phase 3	Completed	Mar 14, 2022	Jun 30, 2023	Papulopustular Rosacea

Competing Products

18 competing products in Papulopustular Rosacea

See all competitors

Product	Company	Stage	Hype Score
Lotilaner Gel, 2.0%	Tarsus Pharmaceuticals	Phase 2	47
Deucravacitinib + Placebo	Bristol Myers Squibb	Phase 2	51
Topical Dapsone 5% Gel + oral antibiotics	Bristol Myers Squibb	Phase 3	76
Azelaic acid (Finacea, BAY39-6251) + Metronidazole (Metrogel) + Doxycycline (Oracea)	Bayer	Approved	82
Azelaic Acid foam 15%	Bayer	Approved	82
Azelaic acid + Vehicle foam	Bayer	Phase 2	49
Azelaic acid foam 15% + Vehicle foam	Bayer	Phase 2	49
azelaic acid 15% gel + azelaic acid 15% gel	Bayer	Approved	82
Azelaic Acid Foam + Azelaic Acid Gel	Bayer	Phase 1	30
Azelaic acid foam, 15% (BAY39-6251) + Vehicle foam	Bayer	Phase 3	74
DFD-29 + Doxycycline + Placebo	Dr. Reddy's Laboratories	Phase 3	74
Encapsulated Benzoyl Peroxide Cream	Sol-Gel Technologies	Phase 1	25
S5G4T-1	Sol-Gel Technologies	Phase 3	69
S5G4T-1 + S5G4T-2	Sol-Gel Technologies	Phase 3	69
S5G4T-1 + S5G4T-2	Sol-Gel Technologies	Phase 3	69
FMX103 minocycline foam 1.5% + Vehicle foam	Vyne Therapeutics	Phase 3	69
FMX103 1.5%	Vyne Therapeutics	Phase 3	69
FMX103 minocycline foam 1.5% + Vehicle foam	Vyne Therapeutics	Phase 3	69

Other Products from Dr. Reddy's Laboratories

OMEZ 40 + OMEZ 80Approved

Ketorolac Tromethamine + KetoprofenApproved

omeprazole+domperidone SR + omeprazoleApproved

NISEApproved

Levofloxacin + LevofloxacinApproved